Page 159 - 南京医科大学自然版
P. 159

第45卷第12期            严舒桐,刘 琪. 机器学习在类风湿性关节炎诊疗及并发症预测中的研究进展[J].
                 2025年12月                    南京医科大学学报(自然科学版),2025,45(12):1834-1844                      ·1841 ·


                   利益冲突声明:                                       [10]TANAKA M,AKIYAMA Y,MORI K,et al. Machine learn⁃
                   所有作者声明无利益冲突。                                        ing⁃based analyses of contributing factors for the develop⁃
                   Conflict of Interests:                              ment of hypertension:a comparative study[J]. Clin Exp
                   All authors declare no conflict of interests.       Hypertens,2025,47(1):2449613
                   作者贡献声明:                                       [11]SARKER I H. Machine learning:algorithms,real ⁃ world
                   严舒桐负责文献检索、论文初稿撰写;刘琪负责选题指                            applications and research directions[J]. SN Comput Sci,
                导、论文检查审核修订。                                            2021,2(3):160
                   Author’s Contributions:                       [12]HU X L,LIU X M,XU Y,et al. Machine learning⁃based
                   YAN Shutong was responsible for literature search,initial  prediction model integrating ultrasound scores and clini⁃
                draft writing of paper;LIU Qi was responsible for topic selec⁃  cal features for the progression to rheumatoid arthritis in
                tion guidance,paper inspection,review and revision.    patients with undifferentiated arthritis[J]. Clin Rheuma⁃
                                                                       tol,2025,44(2):649-659
               [参考文献]
                                                                 [13]HE X L,WANG M,ZHAO C Y,et al. Deep learning ⁃
               [1] DONG Q,WU J Y,ZHANG H G,et al. Deciphering im⁃
                                                                      based automatic scoring models for the disease activity of
                    munometabolic landscape in rheumatoid arthritis:integra⁃
                                                                      rheumatoid arthritis based on multimodal ultrasound ima⁃
                    tive multiomics,explainable machine learning and experi⁃
                                                                      ges[J]. Rheumatology(Oxford),2024,63(3):866-873
                    mental validation[J]. J Inflamm Res,2025,18:637-652
                                                                 [14]SAITO R,FUJII T,MURATA K,et al. Prediction models
               [2] YANG F H,LV J Q,HUANG Y L,et al. A supramolecu⁃
                                                                       incorporating second metacarpal cortical index for osteo⁃
                    lar assembly strategy for the treatment of rheumatoid ar⁃  porosis in rheumatoid arthritis:externally validated ma⁃
                    thritis with ultrasound⁃augmented inflammatory microen⁃  chine learning models developed using data from the
                    vironment reprograming[J]. Biomaterials,2025,316:  KURAMA cohort[J]. Int J Rheum Dis,2024,27(10):

                    123006                                             e15358
               [3] AO Y,LAN Q,YU T H,et al. Cellular senescence⁃associ⁃  [15]MCDERMOTT G C,HAYASHI K,YOSHIDA K,et al.
                    ated genes in rheumatoid arthritis:Identification and func⁃  Rheumatoid arthritis,quantitative parenchymal lung fea⁃
                    tional analysis[J]. PLoS One,2025,20(1):e0317364   tures and mortality among smokers[J]. Rheumatology
               [4] SAWAN S,KUMARI A,MAJIE A,et al. siRNA ⁃ based      (Oxford),2025,64(1):133-142
                    nanotherapeutic approaches for targeted delivery in rheu⁃  [16]朱巧英,丁  炎,宣  旻,等. 类风湿性关节炎超声评分
                    matoid arthritis[J]. Biomater Adv,2025,168:214120  与 DAS⁃28 评分的相关性研究[J]. 南京医科大学学报
               [5] MAJITHIA V,GERACI S A. Rheumatoid arthritis:diag⁃  (自然科学版),2019,39(1):90-93
                    nosis and management[J]. Am J Med,2007,120(11):    ZHU Q Y,DING Y,XUAN W,et al. Study on the correla⁃

                    936⁃939                                            tion between ultrasound score and DAS⁃28 score in rheu⁃
               [6] VITTECOQ O,BREVET P,GERARD B,et al. On difficul⁃    matoid arthritis[J]. Journal of Nanjing Medical University
                    ties to define prognostic factors for clinical practice in  (Natural Sciences),2019,39(1):90-93
                    rheumatoid arthritis[J]. RMD Open,2024,10(3):  [17]ZHOU W Y,YANG Y Y,SU L. Development and valida⁃
                    e004472                                            tion of predictive factors influencing rheumatoid arthritis
               [7] PARK S H,JEON H L,KIM S C,et al. Utilization of tar⁃  associated with interstitial lung disease[J]. Clin Rheuma⁃
                    geted disease⁃modifying anti⁃rheumatic drugs(DMARDs)  tol,2025,44(2):601-613
                    for managing rheumatoid arthritis in the last decade:a two⁃  [18]RAJPURKAR P,IRVIN J,BALL R L,et al. Deep learn⁃
                    country comparison[J]. Int J Clin Pharmacol Ther,2021,  ing for chest radiograph diagnosis:a retrospective compar⁃
                    59(10):639-644                                     ison of the CheXNeXt algorithm to practicing radiolo⁃
               [8] COX N,MALLEN C D,SCOTT I C. Pharmacological pain    gists[J]. PLoS Med,2018,15(11):e1002686
                    management in patients with rheumatoid arthritis:a narra⁃  [19]O’NEIL L J,SPICER V,SMOLIK I,et al. Association of
                    tive literature review[J]. BMC Med,2025,23(1):54   a serum protein signature with rheumatoid arthritis develop⁃
               [9] KERSCHBAUMER A,SEPRIANO A,SMOLEN J S,et al.         ment[J]. Arthritis Rheumatol,2021,73(1):78-88
                    Efficacy of pharmacological treatment in rheumatoid  [20]PRATT A G,SWAN D C,RICHARDSON S,et al. A CD4
                    arthritis:a systematic literature research informing the  T cell gene signature for early rheumatoid arthritis impli⁃
                    2019 update of the EULAR recommendations for manage⁃  cates interleukin 6⁃mediated STAT3 signalling,particu⁃
                    ment of rheumatoid arthritis[J]. Ann Rheum Dis,2020,  larly in anti⁃citrullinated peptide antibody⁃negative dis⁃
                    79(6):744-759                                      ease[J]. Ann Rheum Dis,2012,71(8):1374-1381
   154   155   156   157   158   159   160   161   162   163   164